Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.
PLoS One. 2023 Feb 2;18(2):e0280165. doi: 10.1371/journal.pone.0280165. eCollection 2023.
PLoS One. 2023.
PMID: 36730135
Free PMC article.
Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
Kondili LA, Andreoni M, Aghemo A, Mastroianni CM, Merolla R, Gallinaro V, D'Offizi G, Craxì A.
Kondili LA, et al.
Liver Int. 2023 Dec;43(12):2615-2624. doi: 10.1111/liv.15712. Epub 2023 Sep 21.
Liver Int. 2023.
PMID: 37735959
Item in Clipboard
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: a mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021.
Kondili LA, Andreoni M, Aghemo A, Mastroianni CM, Merolla R, Gallinaro V, Craxì A.
Kondili LA, et al.
New Microbiol. 2022 Dec;45(4):249-259. Epub 2022 May 25.
New Microbiol. 2022.
PMID: 36066213
Free article.
Item in Clipboard
Cite
Cite